PT2851085T - Composição proteica esterilizada por radiação - Google Patents

Composição proteica esterilizada por radiação

Info

Publication number
PT2851085T
PT2851085T PT137915682T PT13791568T PT2851085T PT 2851085 T PT2851085 T PT 2851085T PT 137915682 T PT137915682 T PT 137915682T PT 13791568 T PT13791568 T PT 13791568T PT 2851085 T PT2851085 T PT 2851085T
Authority
PT
Portugal
Prior art keywords
ccomposition
sterilized
protein
radiation
protein ccomposition
Prior art date
Application number
PT137915682T
Other languages
English (en)
Portuguese (pt)
Inventor
Kageyama Yukako
Fujinaga Kentaro
Yamaguchi Ayuko
Honda Susumu
Satake Makoto
Kaneko Hiroaki
Ishiwari Ayumi
Original Assignee
Teijin Pharma Ltd
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Pharma Ltd, Teijin Ltd filed Critical Teijin Pharma Ltd
Publication of PT2851085T publication Critical patent/PT2851085T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01021—Beta-glucosidase (3.2.1.21)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/01—Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01003—Triacylglycerol lipase (3.1.1.3)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Moulding By Coating Moulds (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
PT137915682T 2012-05-14 2013-05-13 Composição proteica esterilizada por radiação PT2851085T (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2012110390 2012-05-14
JP2012110765 2012-05-14
JP2013040593 2013-03-01

Publications (1)

Publication Number Publication Date
PT2851085T true PT2851085T (pt) 2019-10-11

Family

ID=49583866

Family Applications (1)

Application Number Title Priority Date Filing Date
PT137915682T PT2851085T (pt) 2012-05-14 2013-05-13 Composição proteica esterilizada por radiação

Country Status (17)

Country Link
US (1) US10071061B2 (cg-RX-API-DMAC10.html)
EP (1) EP2851085B1 (cg-RX-API-DMAC10.html)
JP (1) JP5746430B2 (cg-RX-API-DMAC10.html)
KR (1) KR102037555B1 (cg-RX-API-DMAC10.html)
CN (1) CN104284673B (cg-RX-API-DMAC10.html)
AU (1) AU2013261308B2 (cg-RX-API-DMAC10.html)
BR (1) BR112014028443B1 (cg-RX-API-DMAC10.html)
CA (1) CA2873602C (cg-RX-API-DMAC10.html)
DK (1) DK2851085T3 (cg-RX-API-DMAC10.html)
ES (1) ES2746300T3 (cg-RX-API-DMAC10.html)
IN (1) IN2014DN09621A (cg-RX-API-DMAC10.html)
MX (1) MX356545B (cg-RX-API-DMAC10.html)
PL (1) PL2851085T3 (cg-RX-API-DMAC10.html)
PT (1) PT2851085T (cg-RX-API-DMAC10.html)
RU (1) RU2695522C2 (cg-RX-API-DMAC10.html)
TW (1) TWI636799B (cg-RX-API-DMAC10.html)
WO (1) WO2013172468A1 (cg-RX-API-DMAC10.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5844894B2 (ja) 2012-05-14 2016-01-20 帝人株式会社 シート成形体および止血材
US11311017B2 (en) 2014-04-30 2022-04-26 Matoke Holdings Limited Antimicrobial compositions
HK1246699A1 (zh) * 2015-02-03 2018-09-14 Matoke Holdings Limited 抗微生物纤维和组合物
FR3036707B1 (fr) * 2015-05-29 2019-05-17 Maco Pharma Procede de sterilisation d'un lysat plaquettaire
GB201716986D0 (en) 2017-10-16 2017-11-29 Matoke Holdings Ltd Antimicrobial compositions
CN113710192B (zh) 2019-01-31 2024-03-15 细胞医药股份有限公司 无机盐类蛋白复合医疗器械

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2209937B (en) 1987-09-21 1991-07-03 Depiopharm S A Water insoluble polypeptides
JPH0622570B2 (ja) 1989-01-31 1994-03-30 多木化学株式会社 生体材料
US5439688A (en) 1989-07-28 1995-08-08 Debio Recherche Pharmaceutique S.A. Process for preparing a pharmaceutical composition
CH679207A5 (cg-RX-API-DMAC10.html) 1989-07-28 1992-01-15 Debiopharm Sa
US5225205A (en) 1989-07-28 1993-07-06 Debiopharm S.A. Pharmaceutical composition in the form of microparticles
CA2033046C (en) 1990-01-12 1999-08-03 Lowell Saferstein Process for preparing a neutralized oxidized cellulose product and its method of use
JP3351525B2 (ja) 1991-06-21 2002-11-25 ジェネティックス・インスティテュート・インコーポレイテッド 骨形成性蛋白医薬処方物
CH683149A5 (fr) 1991-07-22 1994-01-31 Debio Rech Pharma Sa Procédé pour la préparation de microsphères en matériau polymère biodégradable.
GB9206509D0 (en) 1992-03-25 1992-05-06 Jevco Ltd Heteromorphic sponges containing active agents
US5730933A (en) 1996-04-16 1998-03-24 Depuy Orthopaedics, Inc. Radiation sterilization of biologically active compounds
US5945128A (en) 1996-09-04 1999-08-31 Romano Deghenghi Process to manufacture implants containing bioactive peptides
GB2344519B (en) * 1998-12-07 2004-05-19 Johnson & Johnson Medical Ltd Sterile therapeutic compositions
US8076448B2 (en) 2006-10-11 2011-12-13 Tolmar Therapeutics, Inc. Preparation of biodegradable polyesters with low-burst properties by supercritical fluid extraction
ES2516695T3 (es) 2006-10-11 2014-10-31 Tolmar Therapeutics, Inc. Preparación de poliésteres biodegradables con bajas propiedades de absorción rápida mediante extracción de fluido supercrítico
CA2695288A1 (en) * 2007-08-01 2009-02-05 Ethicon, Inc. Collagen-related peptides and uses thereof
AR074603A1 (es) * 2008-12-15 2011-01-26 Novartis Ag Formulacion de deposito de octreotida con niveles de exposicion constantemente altos.uso. metodo. kit
KR20140090704A (ko) * 2009-03-10 2014-07-17 메드프린 리제너레이티브 메디컬 테크놀러지스 컴퍼니 리미티드 인공 경질막 및 인공 경질막의 제조방법
JP5555928B2 (ja) * 2009-08-28 2014-07-23 日本バイリーン株式会社 酵素含有ナノファイバーの製造方法、酵素含有ナノファイバー、この酵素含有ナノファイバーを含む不織布及びこの不織布を用いた反応装置
WO2011138974A1 (ja) * 2010-05-07 2011-11-10 帝人株式会社 生体糊用補強材及びその製造方法
US8273369B2 (en) 2010-05-17 2012-09-25 Ethicon, Inc. Reinforced absorbable synthetic matrix for hemostatic applications
EP2575775B1 (en) * 2010-06-01 2018-04-04 Baxter International Inc. Process for making dry and stable hemostatic compositions
JP5792442B2 (ja) * 2010-09-01 2015-10-14 帝人株式会社 細胞特異的ペプチドを含有する繊維構造体

Also Published As

Publication number Publication date
JP5746430B2 (ja) 2015-07-08
KR20150023253A (ko) 2015-03-05
AU2013261308A1 (en) 2014-12-04
TWI636799B (zh) 2018-10-01
JPWO2013172468A1 (ja) 2016-01-12
ES2746300T3 (es) 2020-03-05
IN2014DN09621A (cg-RX-API-DMAC10.html) 2015-07-31
CA2873602A1 (en) 2013-11-21
MX356545B (es) 2018-06-01
WO2013172468A1 (ja) 2013-11-21
CA2873602C (en) 2022-08-16
RU2014150498A (ru) 2016-07-10
US10071061B2 (en) 2018-09-11
AU2013261308B2 (en) 2018-02-08
BR112014028443B1 (pt) 2021-01-19
HK1204947A1 (en) 2015-12-11
BR112014028443A2 (pt) 2017-06-27
EP2851085A1 (en) 2015-03-25
PL2851085T3 (pl) 2019-12-31
TW201350147A (zh) 2013-12-16
CN104284673B (zh) 2018-02-13
DK2851085T3 (da) 2019-09-09
MX2014013818A (es) 2015-05-11
CN104284673A (zh) 2015-01-14
BR112014028443A8 (pt) 2018-02-06
US20150125511A1 (en) 2015-05-07
KR102037555B1 (ko) 2019-10-28
EP2851085B1 (en) 2019-06-26
EP2851085A4 (en) 2015-04-15
RU2695522C2 (ru) 2019-07-23

Similar Documents

Publication Publication Date Title
SG11201501184XA (en) Implant
EP2911598A4 (en) SURGICAL SYSTEM
EP2796105A4 (en) SURGICAL SYSTEM
IL228053A0 (en) Bra for radiation therapy
IL236930A0 (en) medical system
GB201420925D0 (en) Sterilization device
ZA201406102B (en) An implant
EP2872028A4 (en) MEDICAL SYSTEM
PL2825212T3 (pl) Ulepszony sposób sterylizacji
EP2881048A4 (en) MEDICAL MANIPULATOR
AU348530S (en) Wheelchair
GB201201927D0 (en) Wheelchair
EP2896349A4 (en) MEDICAL SYSTEM
PT2851085T (pt) Composição proteica esterilizada por radiação
GB201207305D0 (en) Therapy
GB201503568D0 (en) Sterilization system for aquaculture
GB201210398D0 (en) Crop enhancement
SG11201405308XA (en) Sterilization method
SG2014007694A (en) Radiation source
EP2870943A4 (en) MEDICAL MANIPULATOR
GB201207882D0 (en) Implant
GB201217281D0 (en) Disinfectant formulation - MS71
PL2633749T3 (pl) Maszyna żniwna
EP2740398A4 (en) MEDICAL SYSTEM
GB201213672D0 (en) Protein